- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04060251
Is There an Alternative to Immediate Home Physical Therapy Following Total Knee Arthroplasty
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02130
- Brigham and Women's Faulkner Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 18 or older
- Owns a device with internet connection
- Can download the E-vive application for the contractile garment (has sufficiently up-to-date phone or tablet, or has family member with such a device).
- Has a rudimentary understanding of Internet technology, especially e-mail
- Has a flexion of 90 o and flexion contracture of 5 o at the point of discharge
- Approved by a physical therapist to participate safely in the study at the time of discharge
Exclusion Criteria:
- Rheumatoid arthritis
- History of epilepsy
- Implanted and body-worn electronic medical device, including cardiac pacemakers, neural stimulators, insulin pumps, etc.
- Poor understanding of the use of the brace/electrical stimulation
- Lesions on the skin over the thigh
- Uncontrolled diabetes
- Uncontrolled hypertension
- Bilateral TKA or UKA planned
- If female, pregnant
- Cannot use non-operated leg postoperatively to propel active motion splint, caused by neurological or muscular diseases such as complete or incomplete paralysis or other causes of weakness with an inability to bend or extend knee
- Loss of sensation in operated or non-operated leg
- Has below- or above-knee amputations of non-operative leg
- Below- knee amputation of operated side
- Chronic pain syndrome with inability to walk
- Taking chronic narcotics and/or is taking more than 10mg codeine per day, or any Hydrocodone, or more than 200 mg of tramadol, or any other narcotics prescribed for moderate to severe pain
- Involved in pain clinics for chronic pain, or pain that is not related to the knee
- Has been diagnosed with knee disorder other than osteoarthritis, post-traumatic osteoarthritis, gout, pseudo gout, or any inability to walk due to disorders unrelated to the knee (e.g., hip disorders, spinal stenosis, paralysis, hemi-paralysis)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Group 1, iGetBetter Group
Use only iGetBetter for the 3 months preceding surgery.
After surgery, you will be given a new, Post-Op program to use for 2-3 months.
For the first 3 weeks, you will only use iGetBetter.
After those 3 weeks, you will receive outpatient physical therapy in addition to iGetBetter, approximately twice per week for the next 6-8 weeks.
|
Group 1 patients will only use a Post-Op program from iGetBetter for the first 3 weeks after surgery.
After those 3 weeks have elapsed, Group 1 patients will receive outpatient physical therapy in addition to iGetBetter, approximately twice per week for the next 6-8 weeks as all other groups.
|
Experimental: Group 2, E-vive Group
You will use iGetBetter starting 3 months out from surgery.
You will receive CyMedica's electrical-stimulation garment during the preoperative appointment.
In addition to iGetBetter, you will wear the conductive garment two times each day for the last 3 weeks before surgery.
After surgery, for the first 3 weeks you will only use the conductive garment, and will not use iGetBetter.
After those 3 weeks, you will receive outpatient physical therapy in addition to wearing the brace, approximately twice per week for the next 6-8 weeks.
You will not need to return the brace after this time is up, and you may keep the brace, if you so choose, at no cost.
|
All the patients in Group 2 will be given the CyMedica Orthopedics e-vive system 3 weeks before the surgery. The patients will begin using the unit after their first pre-intervention measurements are taken. Patients will be instructed to apply the e-vive NMES Strength therapy twice a day, 5 days a week. The NMES Strength program is 20 minutes in length. Treatment intensity (adjustable from 1 to 100 in NMES programs) is required to be set at the highest tolerable limit for the patients. Stimulation from the garment will have the following parameters: frequency of 50 Hz; pulse duration of 5 ms; time on: 12.8 seconds; and time off: 10 seconds. The total contraction time in a 20-minute treatment will be 11 minutes. The waveform will be pulsed and asymmetrical.
Other Names:
|
No Intervention: Group 3, Physical Therapy Group
You will receive only iGetBetter for the 3 months preceding surgery.
After surgery, you will receive only home physical therapy, and will not use iGetBetter.
After those three weeks, you will receive outpatient physical therapy approximately twice per week for the next 6-8 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quadriceps Strength
Time Frame: Preoperative and postoperative appointments (2 months after surgery)
|
Change in quadriceps strength in lbs of force, as measured by PT dynamometer
|
Preoperative and postoperative appointments (2 months after surgery)
|
Balancing
Time Frame: Preoperative and postoperative appointments (2 months after surgery)
|
Change in proprioception (balance) as measured by 30-second single limb stance PT test
|
Preoperative and postoperative appointments (2 months after surgery)
|
Sit-to-stand Time
Time Frame: Preoperative (varies) and postoperative appointments (2 months after surgery)
|
Change in sit-to-stand capabilities
|
Preoperative (varies) and postoperative appointments (2 months after surgery)
|
2 Minute Walking Time
Time Frame: Preoperative and postoperative appointments (2 months after surgery)
|
Change in distance walked in 2 minutes
|
Preoperative and postoperative appointments (2 months after surgery)
|
Walking Speed
Time Frame: Preoperative and postoperative appointments (2 months after surgery)
|
Change in walking speed
|
Preoperative and postoperative appointments (2 months after surgery)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual Analogue Scale (VAS) Pain
Time Frame: first postoperative months (from days post-op through 2-month post-operative appointment)
|
Change in Visual Analog Scale for pain (1-10) 1 no pain 10 worse
|
first postoperative months (from days post-op through 2-month post-operative appointment)
|
Visual Analogue Scale (VAS) Nausea
Time Frame: first postoperative months (from days post-op through 2-month post-operative appointment)
|
Change in VAS nausea (Visual Analog Scale for nausea (1-10) 1 no nausea 10 worse nausea )
|
first postoperative months (from days post-op through 2-month post-operative appointment)
|
Visual Analogue Scale (VAS) Satisfaction
Time Frame: first postoperative months (from days post-op through 2-month post-operative appointment)
|
Change in VAS satisfaction (Visual Analog Scale for satisfaction (1-10) 1 not satisfied, 10 totally unsatisfied)
|
first postoperative months (from days post-op through 2-month post-operative appointment)
|
Readmission Rate
Time Frame: Noted by PI at 2nd postoperative appointment (about 10 weeks after surgery)
|
major complication
|
Noted by PI at 2nd postoperative appointment (about 10 weeks after surgery)
|
Infection Rate
Time Frame: Noted by PI at 2nd postoperative appointment (about 10 weeks after surgery)
|
superficial and deep infection
|
Noted by PI at 2nd postoperative appointment (about 10 weeks after surgery)
|
Cost Per Treatment Regimen (iGetBetter vs. CyMedica E-vive vs. Home PT)
Time Frame: Completion of study (anticipate one year from start data 4/4/2019)
|
We will calculate the total cost of each treatment modality
|
Completion of study (anticipate one year from start data 4/4/2019)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Wolfgang Fitz, MD, Brigham and Women's Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2018P000932
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Total Knee Arthroplasty
-
Limacorporate S.p.aRecruitingTotal Knee Arthroplasty | Revision Total Knee ArthroplastyUnited Kingdom, Portugal, Slovakia
-
DePuy OrthopaedicsJohnson & Johnson Health and Wellness Solutions, Inc.TerminatedTotal Knee Arthroplasty; Total Hip ArthroplastyUnited States
-
DePuy OrthopaedicsJohnson & Johnson Health and Wellness Solutions, Inc.TerminatedTotal Knee Arthroplasty; Total Hip ArthroplastyUnited States
-
Northern Orthopaedic Division, DenmarkCompletedTotal Knee Arthroplasty | Total Hip ArthroplastyDenmark
-
Singapore General HospitalCompletedTotal Knee Arthroplasty | Total Knee ReplacementSingapore
-
Istanbul UniversityCompleted
-
Istanbul UniversityCompletedTotal Knee Arthroplasty | Total Knee ReplacementTurkey
-
Smith & Nephew, Inc.Completed
-
University of AlbertaCompletedArthroplasty, Replacement, Knee | Knee Arthroplasty, TotalCanada
-
University of North Carolina, Chapel HillNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedKnee Arthroplasty, Total | Knee Replacement, TotalUnited States
Clinical Trials on iGetBetter telemedicine physical therapy
-
Fondazione Salvatore MaugeriUnknownParkinson's Disease
-
Riphah International UniversityCompleted
-
Mayo ClinicNot yet recruitingFIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma | Stage IA Uterine Corpus Cancer AJCC v8 | Stage IB Uterine Corpus Cancer AJCC v8United States
-
Medical University of South CarolinaCompletedHead and Neck Squamous Cell Carcinoma | Body Image DisturbanceUnited States
-
University of South FloridaNational Institute of Mental Health (NIMH)RecruitingArachnophobia | Cynophobia | OphidiophobiaUnited States
-
Mayo ClinicDePuy OrthopaedicsCompleted
-
International Hellenic UniversityNot yet recruitingChronic Pain | Neuropathic Pain | Cognitive Therapy
-
Universidad de ZaragozaCompletedPlagiocephaly | Plagiocephaly, Nonsynostotic | Plagiocephaly, PositionalSpain
-
Riphah International UniversityCompletedAdhesive Capsulitis of ShoulderPakistan